Natural relief for a life with no limits.

  • Innovative solution for neuropathic pain relief
  • Active synergy on type 2 cannabinoid receptors (CB2)
  • Patent pending

Algistat®, an innovative formulation based on clove essential oil and docosahexaenoic acid (DHA), is an innovative ingredient for the management of neuropathic and inflammatory pain.

Algistat® is a completely natural, innovative ingredient for dietary supplements with anti-inflammatory, analgesic, and antioxidant properties. It features a patent pending formulation based on Clove Essential Oil (Syzygium aromaticum) and Docosahexaenoic Acid (DHA). In vitro studies conducted at the Universities of Bologna and Siena, in Italy, have confirmed its synergistic action in counteracting low-grade chronic inflammatory pain. Currently, an open-label interventional clinical study is underway in collaboration with the patient association Comitato Fibromialgici Uniti (CFU Italia) on volunteer subjects diagnosed with Fibromyalgia.

Algistat® is indicated for the formulation of natural dietary supplements to support well-being in cases of inflammatory and nerve discomfort. You can find it in Algistat Complex, learn more.

In the innovative formulation of Algistat®, clove oil, which contains eugenol and beta-caryophyllene, and docosahexaenoic acid have an anti-inflammatory and analgesic effect. DHA belongs to the class of omega-3 fatty acids, known for its neuroprotective and anti-inflammatory effects, while the main components of clove essential oil act as agonists of type 2 cannabinoid receptors (CB-2) and have a powerful antioxidant effect.

Do you have questions?
We have the answers

Algistat® is an innovative natural raw material for the formulation of dietary supplements. It contains Clove essential oil (Syzygium aromaticum Merr. et L.M. Perry) and DHA, providing excellent support for antioxidant defenses and the well-being of the nervous system.

The oral intake of Clove Essential Oil and DHA at the dosages found in Algistat®, based on EFSA (European Food Safety Authority) recommendations, is considered safe. Furthermore, the lack of adverse effects at the recommended dosages makes Algistat® safe for prolonged use.

The particular formulation of Algistat® complex ensures that Clove Essential Oil and DHA are easily absorbed in the intestine. This allows for maximizing the antioxidant effect and the beneficial impact on the nervous system.

It is a versatile raw material that can be produced both in powder form for capsule formulations and in liquid form for softgel production. The Clove Essential Oil (Syzygium aromaticum Merr. et L.M. Perry) undergoes a microencapsulation process, followed by blending with DHA.

Algistat® is GMO-free. It does not contain, derive from, or consist of Genetically Modified Organisms. Algistat® complies with Regulations CE 1829/2003 and 1830/2003. In particular: Regulation (CE) No. 1829/2003 of the European Parliament and of the Council, dated 22 September 2003, on genetically modified food and feed, and Regulation (CE) No. 1830/2003 of the European Parliament and of the Council, dated 22 September 2003, on the traceability and labeling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms.

The Essential Oil of Cloves comes from Indonesia, while the product processing takes place in Italy.

Discover the related supplement
Articles about it
Informativa | Questo sito web utilizza i cookie ×

Questo sito web utilizza i cookie per migliorare la tua esperienza di navigazione.
Utilizzando il nostro sito web acconsenti ai cookie in conformità con la nostra policy per i cookie. I cookie non necessari devono essere approvati prima di poter essere impostati nel browser.
Puoi modificare il tuo consenso all'utilizzo dei cookie in qualsiasi momento cliccando sull'icona di ProntoGDPR in basso a sinistra.
Cliccando sulla X in alto a destra rifiuti tutti i cookie e accetti la memorizzazione dei soli cookie necessari.

Cookie Preferences: